Adam Hansard

Insider Reports History

Entity
Individual
Location
C/O Applied Therapeutics, Inc., 545 5 Th Avenue, Suite 1400, New York, NY
Signature
/s/ Shoshana Shendelman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam Hansard:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Applied Therapeutics, Inc. Chief Commercial Officer Common Stock 733K $3.95M $5.39 Mar 14, 2024 Direct

Insider Reports Filed by Adam Hansard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLT Applied Therapeutics, Inc. Mar 14, 2024 1 -$263K 4 Mar 18, 2024 Chief Commercial Officer
APLT Applied Therapeutics Inc. Dec 21, 2023 1 $0 4 Dec 22, 2023 Chief Commercial Officer
APLT Applied Therapeutics Inc. Nov 30, 2023 1 -$1.9K 4 Dec 1, 2023 Chief Commercial Officer
APLT Applied Therapeutics Inc. Sep 27, 2023 1 -$26.2K 4 Sep 29, 2023 Chief Commercial Officer
APLT Applied Therapeutics Inc. Jan 11, 2023 2 -$4.09K 4 Jan 13, 2023 Chief Commercial Officer
APLT Applied Therapeutics Inc. Aug 2, 2022 10 $0 4 Aug 4, 2022 Chief Commercial Officer
APLT Applied Therapeutics Inc. Apr 13, 2022 1 $0 4 Apr 15, 2022 Chief Commercial Officer
APLT Applied Therapeutics Inc. Jan 7, 2022 2 $0 4 Jan 11, 2022 Chief Commercial Officer
APLT Applied Therapeutics Inc. Dec 14, 2021 1 $0 4/A Jan 11, 2022 Chief Commercial Officer
APLT Applied Therapeutics Inc. May 26, 2021 1 -$53.1K 4 May 28, 2021 Chief Commercial Officer